about
Asymptomatic ventricular preexcitation: a long-term prospective follow-up study of 293 adult patients.Electroanatomical voltage and morphology characteristics in postinfarction patients undergoing ventricular tachycardia ablation: pragmatic approach favoring late potentials abolition.LMNA-associated myopathies: the Italian experience in a large cohort of patients.Predictors of advanced lead extraction based on a systematic stepwise approach: results from a high volume center.New diagnostic criteria for identifying left-sided ventricular ectopy using non-contact mapping and virtual unipolar electrogram analysis.Noninducibility and late potential abolition: a novel combined prognostic procedural end point for catheter ablation of postinfarction ventricular tachycardia.Catheter ablation of ventricular arrhythmia in nonischemic cardiomyopathy: anteroseptal versus inferolateral scar sub-types.Late potentials abolition reduces ventricular tachycardia recurrence after ablation especially in higher-risk patients with a chronic total occlusion in an infarct-related artery.Robotic magnetic navigation for atrial fibrillation ablation.Unexpected acute lymphocytic virus-negative myocarditis in a patient with limited cutaneous systemic sclerosis: a case reportHigh-throughput genetic characterization of a cohort of Brugada syndrome patientsSuccessful use of sirolimus in a patient with cardiac microangiopathy in primary antiphospholipid syndromeImpact of systemic immune-mediated diseases on clinical features and prognosis of patients with biopsy-proved myocarditisArrhythmias in myocarditis: State of the artA randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF StudyLeft atrial tachycardia after circumferential pulmonary vein ablation for atrial fibrillation: electroanatomic characterization and treatmentPrevention of iatrogenic atrial tachycardia after ablation of atrial fibrillation: a prospective randomized study comparing circumferential pulmonary vein ablation with a modified approachAtrial fibrillation progression and management: a 5-year prospective follow-up studyElectrical storm induced by cardiac resynchronization therapy is determined by pacing on epicardial scar and can be successfully managed by catheter ablationSafety and efficacy of open irrigated-tip catheter ablation of Wolff-Parkinson-White syndrome in children and adolescentsImpact of a chronic total occlusion in an infarct-related artery on the long-term outcome of ventricular tachycardia ablationComparison of incidence and predictors of left bundle branch block after transcatheter aortic valve implantation using the CoreValve versus the Edwards valveUpdated clinical overview on cardiac laminopathies: an electrical and mechanical diseaseSubcutaneous implantable cardioverter defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy: Results from an Italian multicenter registryThyroid dysfunction in adult patients with biopsy-proved myocarditis: Screening and characterizationAcute myocarditis presenting as a reverse Tako-Tsubo syndrome in a patient with SARS-CoV-2 respiratory infectionTwo-dimensional and three-dimensional cardiac magnetic resonance feature-tracking myocardial strain analysis in acute myocarditis patients with preserved ejection fractionA novel homozygous mutation in the TRDN gene causes a severe form of pediatric malignant ventricular arrhythmiaCardiac and Neuromuscular Features of Patients with LMNA-Related CardiomyopathyEfficacy and safety of mycophenolate mofetil in patients with virus-negative lymphocytic myocarditis: A prospective cohort studyAcute myocardial injury, MINOCA, or myocarditis? Improving characterization of coronavirus-associated myocardial involvement
P50
Q33157907-C6A19896-DDC8-4652-869B-84453410A60DQ40892257-2A946E62-4794-4676-9278-487BE037A153Q42686080-85ACF2D7-CC73-4899-8BAB-6CEBCAABAD12Q44763903-D55F21FB-9288-4423-A68F-742988517655Q51073919-A066BECA-677E-414A-AB95-5B029DDF6124Q51734894-D6DDBF98-5AC8-4585-8C5A-A02961A01E4FQ51738573-EAC011D5-D3C1-4A1A-91A2-B11935487A2CQ51739843-75001B15-C723-42D1-B1E6-700603CB082BQ51944817-96A2C107-E965-448D-BECC-33B2488457FDQ57064327-4508DFA4-31D0-4F22-93E4-7B0EFF9EFBFAQ58880781-7DFCCA54-B0EC-43CF-8E62-1377D00857B5Q64040352-8C668BD3-E6F1-4278-AEE5-0626FEF25991Q64042078-7D612067-3433-450C-8CB8-0E26ABBBE202Q64042480-0EA3FB7C-FEE8-488F-875C-12CDD5DF2741Q79425842-CF278DD4-A3B4-4743-A198-F60F17901A2AQ80507992-AA6E62F7-03D7-46EC-AB59-82BF4897DFF8Q80946114-899E3F1E-323C-42B6-B581-11BEBF51F6DDQ82239927-89636E3F-C222-45C0-8C57-2DE61868000FQ85310278-A949C61A-1C31-4B47-87A5-B878997F7868Q85973652-443D4542-715A-43C8-8E75-C1F27C49D132Q86552502-96046675-C8F8-4B08-8093-23812AA76123Q86881379-E004FBE7-A95F-410D-A988-2031813C7D6DQ89179955-196428F8-7B10-4157-8E75-19EFD6B5140DQ91129669-9DB8C8C7-22A6-495E-B9B9-ABC5BD7C0066Q91306864-CC419E5D-DF49-4495-A22F-3DA4E37D5F1AQ91725455-A0505F6A-B27A-4907-A3B4-2362F4CB77A4Q92721439-14067D48-38E4-4997-8A85-81A3BFA7F1B2Q92775791-0CC42431-FCF1-4F47-B6B1-6BF1983D6E6FQ93058495-AD13A187-C8D2-4F7D-B221-383956A9DE92Q93130150-2581482C-3687-41E0-978E-983261D326FFQ94503972-F03EB937-0213-44AD-8E65-58FB435AF9E1
P50
description
investigador
@es
researcher
@en
name
Simone Sala
@en
Simone Sala
@nl
type
label
Simone Sala
@en
Simone Sala
@nl
prefLabel
Simone Sala
@en
Simone Sala
@nl
P31
P496
0000-0003-3303-8892